Common Bile Duct Diseases: Clinical Trials

3 trials for Common Bile Duct Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 43Completed 3

Follow Common Bile Duct Diseases: new trials by email Literature Review of Common Bile Duct Diseases trials Research Report on Common Bile Duct Diseases

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Danshu Capsule and Ursodeoxycholic Acid Capsule in Preventing Recurrence of Choledocholithiasis
oral Danshu capsule - Choledocholithiasis, Recurrence
Phase 4CompletedFirst People's Hospital of Hangzhou1502017-03-012020-07-24
Etomidate vs. Midazolam for Sedation During ERCP
Etomidate, Midazolam, Meperidine - Choledocholithiasis, Cholangiocarcinoma
Phase 4CompletedCheju Halla General Hospital632013-04-012015-06-29
A Study of Serial Magnetic Resonance Cholangiopancreatography (MRCP) Following Morphine-neostigmine and Secretin Provocation in Healthy Volunteers
Morphine, Neostigmine, 0.9% saline - Sphincter of Oddi Dysfunction
Phase 4CompletedUniversity of Nottingham102009-01-012010-06-02

Narrower conditions

Choledocholithiasis (2)  ·  Cholangiocarcinoma (1)  ·  Pancreatic Neoplasms (1)  ·  Pancreatitis (1)  ·  Recurrence (1)  ·  Sphincter of Oddi Dysfunction (1)

Broader conditions

Bile Duct Diseases (3)  ·  Biliary Tract Diseases (3)  ·  Digestive System Diseases (3)  ·  Cholelithiasis (2)  ·  Adenocarcinoma (1)  ·  Biliary Dyskinesia (1)  ·  Carcinoma (1)  ·  Digestive System Neoplasms (1)  ·  Disease Attributes (1)  ·  Endocrine Gland Neoplasms (1)  ·  Endocrine System Diseases (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms by Site (1)

Interventions

Etomidate (1)  ·  Meperidine (1)  ·  Midazolam (1)  ·  Morphine (1)  ·  Neostigmine (1)  ·  Saline Solution (1)  ·  Secretin (1)

Sponsors

Cheju Halla General Hospital (1)  ·  First People's Hospital of Hangzhou (1)  ·  University of Nottingham (1)

Countries

China (1)  ·  South Korea (1)  ·  United Kingdom (1)

Top investigators

Abeed Chowdhury, MB ChB BSc MRCS (1)  ·  Dileep Lobo, MBBS DM FRCS (1)  ·  Xiaofeng Zhang, Zhang (1)